Shares of the biotechnology company surged after an FDA advisory committee voted 10-3 in favor of the efficacy data for its advanced melanoma therapy, RP1, boosting hopes for regulatory approval.
The Swiss technology group reported strong organic sales growth and a profit beat for the first half of 2026, while providing its first quantitative sales and margin outlook for the full fiscal year.
Nuclear technology and services supplier Westinghouse Electric Company has confidentially submitted a draft registration statement with the U.S. Securities and Exchange Commission for a proposed IPO.
Logistics solutions provider Interroll announced first-half 2026 results where sales surpassed forecasts, but net income fell short of consensus due to higher taxes. The company maintained its outlook while warning of macroeconomic challenges.
The Swiss medical device company's H1 revenue of €368 million fell short of the €373 million consensus, driven by weaker sales in its Knees, Spine, and Shoulder segments and the slowest growth in North America.
Nuclear power company Westinghouse Electric, jointly owned by Cameco and Brookfield Renewable Partners, has submitted a draft registration with the SEC for a proposed IPO.
The European Commission has charged the Chinese-owned e-commerce platform for failing to cooperate with an inspection at its Dublin headquarters. The raid was part of an investigation into potentially distorting foreign subsidies.
German insurer Allianz announced it will terminate a legacy employee equity program at its U.S. asset management subsidiary, PIMCO, paying at least €1.4 billion ($1.61 billion) to acquire stakes held by former staff.
The alternative asset manager reported record second-quarter inflows driven by institutional investors, pushing its assets under management to $671.3 billion and growing its uninvested capital to a record $170 billion.
